Utilization of the TAD Device for Dispensing Pain Medications in Hospice Patients

Completed · Not applicable

Conditions studied: Medication Adherence, Satisfaction, Personal

In brief

A novel device, TAD, has been developed to aid adherence to prescribed regimens and may have a roll in hospice pain management. This study aims to assess medication adherence relating to missed doses or improperly timed doses with and without the aid of a mobile device as a primary endpoint. Secondary endpoints will be patient, nursing, and provider satisfaction.

Key facts

Study ID

NCT03940534

Run by

Intent Solutions, Inc.

People needed

8

Starts

2018-03-09

Expected to finish

2019-02-26

Last updated by the study team

2019-05-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• any patient taking morphine ER or Oxycontin on one of three hospice home teams

You may not qualify if…

• pregnancy
• inability to demonstrate competent use of the device
• age less than 18

Where it is running

• Haven: Advanced Illness Care — Gainesville, Florida, United States
• Haven: Advanced Illness Care — Lake City, Florida, United States
• Haven: Advanced Illness Care — Palatka, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.